Science has taught us that many diseases – including HIV, HCV and cancer – can only be controlled by cocktails containing several drugs. Business has taught us that the best drugs don't necessarily come from your own pipeline, and they aren't always for sale. Hence the rise of no-money, no-rights, no-strings-attached deals to combine multiple unapproved drugs from multiple sponsors in a single clinical trial. Read More
